The SAVI-TF Registry: 1-Year Outcomes of the European Post-Market Registry Using the ACURATE neo Transcatheter Heart Valve Under Real-World Conditions in 1,000 Patients

JACC: Cardiovascular Interventions

Volumn 11, Issue 14, 2018, Pages 1368-1374

  Kim, Won Keun ^a   Hengstenberg, Christian ^b,c,d   Hilker, Michael ^e   Kerber, Sebastian ^f   Schäfer, Ulrich ^g   Rudolph, Tanja ^h   Linke, Axel ⁱ   Franz, Norbert ^j   Kuntze, Thomas ^k   Nef, Holger ^l   Kappert, Utz ^m   Zembala, Michael O ⁿ   Toggweiler, Stefan ^o   Walther, Thomas ^a,p   Möllmann, Helge ^a,q  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^f Bad Neustadt an der Saale ^*  (Germany)

^g UNIVERSITY HEART CENTER HAMBURG   (Germany)

^h UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

ⁱ UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^j Schüchtermann Schiller'sche Kliniken   (Germany)

^k Central Hospital Bad Berka   (Germany)

^l UNIVERSITY HOSPITAL GIESSEN   (Germany)

^m University Heart Center Dresden   (Germany)

ⁿ MEDICAL UNIVERSITY OF SILESIA   (Poland)

^o LUZERNER KANTONSSPITAL   (Switzerland)

^p UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^q ST JOHANNES HOSPITAL   (Germany)

more..

Author keywords

ACURATE neo; aortic stenosis; TAVR; transcatheter aortic valve replacement; transfemoral

Indexed keywords

AGED; AORTIC VALVE REPLACEMENT; ARTICLE; CEREBROVASCULAR ACCIDENT; EUROSCORE; FEMALE; HEART VALVE REPLACEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PACEMAKER IMPLANTATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOCIETY OF THORACIC SURGEONS SCORE; TRANSCATHETER AORTIC VALVE IMPLANTATION; VALVE IN VALVE REPLACEMENT; ADVERSE EVENT; AORTIC VALVE; AORTIC VALVE STENOSIS; BIOPROSTHESIS; CALCINOSIS; CLINICAL TRIAL; CONVALESCENCE; DEVICES; DIAGNOSTIC IMAGING; EUROPE; HEART PACING; HEART VALVE PROSTHESIS; HEMODYNAMICS; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY; POSTMARKETING SURVEILLANCE; POSTOPERATIVE COMPLICATION; PROSTHESIS DESIGN; REGISTER; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; BIOPROSTHESIS; CALCINOSIS; CARDIAC PACING, ARTIFICIAL; EUROPE; FEMALE; HEART VALVE PROSTHESIS; HEMODYNAMICS; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; PRODUCT SURVEILLANCE, POSTMARKETING; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RECOVERY OF FUNCTION; REGISTRIES; RISK FACTORS; TIME FACTORS; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 85049442253     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2018.03.023     Document Type: Article

References (16)

1. Jones, B.M., Krishnaswamy, A., Tuzcu, E.M., et al. Matching patients with the ever-expanding range of TAVI devices. Nat Rev Cardiol 14 (2017), 615–626.
2. Barbanti, M., Webb, J.G., Gilard, M., Capodanno, D., Tamburino, C., Transcatheter aortic valve implantation in 2017: state of the art. EuroIntervention 13 (2017), AA11–AA21.
3. Mack, M.J., Leon, M.B., Smith, C.R., et al. 5-Year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385 (2015), 2477–2484.
4. Gerckens, U., Tamburino, C., Bleiziffer, S., et al. Final 5-year clinical and echocardiographic results for treatment of severe aortic stenosis with a self-expanding bioprosthesis from the ADVANCE Study. Eur Heart J 38 (2017), 2729–2738.
5. Deeb, G.M., Reardon, M.J., Chetcuti, S., et al. 3-Year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement. J Am Coll Cardiol 67 (2016), 2565–2574.
6. Schäfer, U., Conradi, L., Diemert, P., et al. Symetis ACURATE TAVI: review of the technology, developments and current data with this self-expanding transcatheter heart valve. Minerva Cardioangiol 63 (2015), 359–369.
7. TM prosthesis: one-year outcomes of the multicenter “CE-approval-cohort.”. EuroIntervention 13 (2017), e1040–e1046.
8. Möllmann, H., Hengstenberg, C., Hilker, M., et al. Real-world experience using the ACURATE neo™ prosthesis: 30-day outcomes of 1000 patients enrolled in the SAVI-TF registry. EuroIntervention 13 (2018), e1764–e1770.
9. Kappetein, A.P., Head, S.J., Genereux, P., et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J 33 (2012), 2403–2418.
10. Hamm, K., Reents, W., Zacher, M., et al. Transcatheter aortic valve implantation using the ACURATE TA and ACURATE neo valves: a 4-year single-center experience. EuroIntervention 13 (2017), 53–59.
11. Mauri, V., Kim, W.K., Abumayyaleh, M., et al. Short-term outcome and hemodynamic performance of next-generation self-expanding versus balloon-expandable transcatheter aortic valves in patients with small aortic annulus: a multicenter propensity-matched comparison. Circ Cardiovasc Interv, 10, 2017, e005013.
12. Wendler, O., Schymik, G., Treede, H., et al. SOURCE 3: 1-year outcomes post-transcatheter aortic valve implantation using the latest generation of the balloon-expandable transcatheter heart valve. Eur Heart J 38 (2017), 2717–2726.
13. Linke, A., Wenaweser, P., Gerckens, U., et al. Treatment of aortic stenosis with a self-expanding transcatheter valve: the international multi-centre ADVANCE study. Eur Heart J 35 (2014), 2672–2684.
14. Van Mieghem NM. The RESPOND study at one-year: primary endpoint outcomes with a repositionable and fully retrievable aortic valve in routine clinical practice. Presented at: EuroPCR; May 16, 2017; Paris, France.
15. Husser, O., Kim, W.K., Pellegrini, C., et al. Multicenter comparison of novel self-expanding versus balloon-expandable transcatheter heart valves. J Am Coll Cardiol Intv 10 (2017), 2078–2087.
16. Kim, W.K., Blumenstein, J., Liebetrau, C., et al. Comparison of outcomes using balloon-expandable versus self-expanding transcatheter prostheses according to the extent of aortic valve calcification. Clin Res Cardiol 106 (2017), 995–1004.